Pan-tumor MRD Study

Abroad (travel likely)Recruiting

Conditions

Muscle Invasive Bladder Urothelial Carcinoma · Esophageal Cancer · Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma · Melanoma (Skin Cancer) · NSCLC (Non-small Cell Lung Cancer) · Pancreatic (Exocrine Only) · Mix of Solid Tumors (MOST)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Medical Oncology Associates of San Diego, San Diego, California, United States
Contact: Study coordinator (Alexis Bustamante) · abustamante@oncologysandiego.com
Taylor Cancer Research Center, Maumee, Ohio, United States
Contact: Study coordinator (Jennifer Martinez) · jmartinez@toledoclinic.com · 419-479-5605

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer

Localized Muscle Invasive Bladder Urothelial Carcinoma · Muscle-Invasive Bladder Carcinoma

Abroad (travel likely)RecruitingPHASE1

Cleveland, United States

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Muscle Invasive Bladder Urothelial Carcinoma · Muscle Invasive Renal Pelvis Urothelial Carcinoma · Muscle Invasive Ureter Urothelial Carcinoma

Abroad (travel likely)RecruitingPHASE2, PHASE3

Phoenix, United States · Phoenix, United States

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Non-Muscle Invasive Bladder Urothelial Carcinoma · Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma · Stage I Bladder Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE2

Fayetteville, United States · Rogers, United States

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Muscle Invasive Bladder Urothelial Carcinoma · Stage II Bladder Cancer AJCC v8 · Stage IIIA Bladder Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Gilbert, United States